KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025
RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist…
Ancora Issues Letter to CSXs Board of Directors Regarding the Need to Avert a Permanent Impairment of Value and Aggressively Pursue a Value-Maximizing Merger
Asserts the Board Should Immediately Announce the Formal Retention of an Investment…
